Biostem Technologies To Present At The 46Th Annual TD Cowen Healthcare Conference

2026-02-20 07:11:04

(MENAFN- GlobeNewsWire - Nasdaq) POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today announced that Company management will present at the 46^th Annual TD Cowen Healthcare Conference being held in Boston, MA.

46 ^th Annual TD Cowen Healthcare Conference:

Format: Presentation
Date: Monday, March 2, 2026
Time: 3:50 pm ET

Interested parties may access live and archived webcasts of the presentations on the“investors” section of the Company's website at: biostemtechnologies.

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain^®processing method. BioRetain^®has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). Our portfolio of quality brands includes VENDAJE^®, VENDAJE AC^®, American AmnionTM, American Amnion ACTM, and Neox^® and Clarix^® product lines. For more information visit and follow us on X and LinkedIn.

Join BioStem's Distribution List & Social Media:
To follow the latest developments at BioStem, sign up for the Company's email distribution list HERE, and follow us on X and LinkedIn.

Contact BioStem:
Website:
E-Mail: ...
X: @BSEM_Tech
Facebook: BioStemTechnologies
Phone: 954-380-8342

Investor Relations:
Philip Trip Taylor, Gilmartin
E-Mail: ...

MENAFN20022026004107003653ID1110767738

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.